Post-Operative Nausea And Vomiting Forecast Report – Designed for Decision Makers and Product Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Post-Operative Nausea And Vomiting Market?
There has been substantial expansion in the market size of post-operative nausea and vomiting in the past few years. The market, valued at $2.11 billion in 2024, is projected to escalate to $2.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.4%. This remarkable increase during the historic period can be credited to the escalation in research and development activities, growing inclination for progressive therapies, an uptrend in the expenditure on healthcare, augmented emphasis on personalized medicine, as well as the increasing embrace of digital health technologies.
What Growth Rate Is Forecasted for the Post-Operative Nausea And Vomiting Market by 2029?
In the coming years, the market size for post-operative nausea and vomiting is projected to witness a robust expansion. The market is forecasted to reach $2.97 billion in 2029, with a compound annual growth rate (CAGR) of 7.0%. Several factors contribute to this predicted growth, including an increased demand for pharmaceuticals, the rise of combination therapy, enhanced awareness and investment in healthcare, a surge in the elderly population, and an increase in cancer cases. Key trends anticipated during the forecast period consist of the development of superior antiemetic therapies, strategic affiliations, the introduction of novel drug compositions, the incorporation of cutting-edge diagnostic tools, and the use of electronic simulation devices.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22109&type=smp
Which Key Companies Are Shaping the Future of the Post-Operative Nausea And Vomiting Market?
Major companies operating in the post-operative nausea and vomiting market are Pfizer Inc., Merck KGaA, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited. , Baxter Corporation, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Inc., Fresenius Kabi AG, Eisai Co. Ltd., Dr. Reddy’s Laboratories, Kyowa Hakko Kirin Taiwan Co. Ltd., Cipla Ltd., Alkem Laboratories Ltd., Eagle Pharmaceuticals Inc. , Camurus AB, Helsinn Healthcare SA, Heron Therapeutics Inc., Advacare Pharma
Which Factors Are Driving Demand in the Post-Operative Nausea And Vomiting Industry?
The post-operative nausea and vomiting market is anticipated to expand due to an increase in the number of surgical procedures. Surgical procedures encompass medical interventions that employ instruments to diagnose, treat, or dissect damaged tissues, organs, or anomalies through cutting or manipulation. Owing to advancements in medical technology, surgical processes have become safer, more effective, and less invasive, thereby gaining acceptance from patients and wider applicability. The management of post-operative nausea and vomiting optimises surgical procedures by improving patient comfort, decreasing recovery duration, lessening the risk of complications, facilitating improved post-operative care, and enhancing the overall outcomes of the surgery. For instance, records from the Australian Institute of Health and Welfare, a government agency based in Australia, indicated that 771,600 patients were admitted for surgical procedures from public hospital elective surgery waiting lists in November 2024, marking a 4.9% surge compared to 2022-23. Consequently, the increasing surgical procedures are fuelling the growth of the post-operative nausea and vomiting market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=22109&type=smp
How Is the Post-Operative Nausea And Vomiting Market Segmented by Several Divisions?
The post-operative nausea and vomiting market covered in this report is segmented –
1) By Treatment Type: Serotonin Antagonists, Steroids, Dopamine Antagonists, Neurokinin NK-1 Receptor Antagonists, Non-pharmacological Treatment, Other Treatment Types
2) By Route Of Administration: Oral, Intravenous, Transdermal, Other Route Of Administrations
3) By Patient Demographics: Pediatric Patients, Adult Patients, Geriatric Patients
4) By Surgical Procedure Type: Orthopedic Surgery, Gynecological Surgery, General Surgery, Cardiac Surgery, Ophthalmic Surgery
5) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
Subsegmentss:
1) By Serotonin Antagonists Type: Ondansetron, Granisetron, Palonosetron, Dolasetron, Tropisetron
2) By Steroids Type: Dexamethasone, Methylprednisolone, Hydrocortisone, Prednisolone, Betamethasone
3) By Dopamine Antagonists Type: Metoclopramide, Droperidol, Prochlorperazine, Domperidone, Chlorpromazine
4) By Neurokinin NK-1 Receptor Antagonists Type: Aprepitant, Fosaprepitant, Rolapitant, Netupitant, Casopitant
5) By Non-Pharmacological Treatment Type: Acupressure, Aromatherapy, Hypnotherapy, Electroacupuncture, Ginger Supplements
6) By Other Treatment Types: Antihistamines, Anticholinergics, Cannabinoids, Combination Therapy, Herbal & Natural Remedies
What are the Emerging Market Trends Driving the Growth of the Post-Operative Nausea And Vomiting Industry?
Major businesses in the post-operative nausea and vomiting market are prioritizing the creation of vital injectable drugs. They are using advanced emulsion formulations and prolonged-release technology to enhance efficiency and provide long-term relief for patients after surgery. These critical injectable medications refer to vital drugs given through injections, formulated to offer quick and effective treatment for severe or pressing health issues. For example, Avenacy, a specialty pharmaceutical company based in the US, launched Palonosetron Hydrochloride Injection in 0.25 mg/5 mL single-dose vials in July 2024. This initiative was to help healthcare professionals minimize dosing mistakes and increase patient safety. The injection is used to prevent nausea and vomiting resulting from chemotherapy and to control postoperative nausea and vomiting (PONV) for up to 24 hours after a surgical procedure. It provides a dependable treatment alternative for patients who are susceptible to these conditions.
Access The Full Report Here:
Which Regions Are Driving Growth in the Post-Operative Nausea And Vomiting Market?
North America was the largest region in the post-operative nausea and vomiting market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-operative nausea and vomiting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22109
This Report Delivers Insight On:
1. How big is the post-operative nausea and vomiting market, and how is it changing globally?
2. Who are the major companies in the post-operative nausea and vomiting market, and how are they performing?
3. What are the key opportunities and risks in the post-operative nausea and vomiting market right now?
4. Which products or customer segments are growing the most in the post-operative nausea and vomiting market?
5. What factors are helping or slowing down the growth of the post-operative nausea and vomiting market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
